Table 6. Association of H-RAS T81C Polymorphism With the Clinicopathological Features.

Clinical features	No.	TT	CT	CC	P value
Patients	100	38	61	1	< 0.0001
Controls	100	92	8	0
Males	65	25	39	1	< 0.7
Female	35	13	22	0
CP-CML	50	29	20	1	< 0.0003
AP-CML	25	7	18	0
BC-CML	25	2	23	0
A2b2	31	13	18	0	< 0.9
A2b3	67	24	42	1
A2b2/A2b3	2	1	1	0
Imatinib	100	38	61	1
MMR	52	31	21	0	< 0.0001
No MR	48	7	40	1
MHR	50	26	24	0	< 0.04
Minor HR	10	3	7	0
Loss HR	40	9	30	1
Age > 45	36	11	24	1	< 0.2
Age ≤ 45	64	27	37	0
Thrombocytopenia	50	11	38	1	< 0.003
No thrombocytopenia	50	27	23	0